Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 3.900 | 3.900 | 0.000 |
Stocks | 96.670 | 96.670 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 21.871 | 21.892 |
Price to Book | 5.226 | 4.021 |
Price to Sales | 2.516 | 2.277 |
Price to Cash Flow | 20.750 | 17.046 |
Dividend Yield | 1.022 | 1.338 |
5 Years Earnings Growth | 9.677 | 11.286 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 98.380 | 94.888 |
Consumer Defensive | 1.620 | 3.376 |
Number of long holdings: 32
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly and Co | - | 9.41 | - | - | |
Regeneron Pharmaceuticals Inc | - | 8.51 | - | - | |
Vertex Pharmaceuticals Inc | - | 8.20 | - | - | |
Novo Nordisk B | DK0062498333 | 7.96 | 937.4 | +1.56% | |
AstraZeneca | GB0009895292 | 6.38 | 12,404.0 | +0.36% | |
Amgen Inc | - | 6.19 | - | - | |
Neurocrine Biosciences Inc | - | 4.22 | - | - | |
Gilead Sciences Inc | - | 4.19 | - | - | |
AbbVie Inc | - | 3.68 | - | - | |
Intuitive Surgical Inc | - | 2.98 | - | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Nomura Taiwan Superior Equity Fund | 18.86B | 12.14 | 14.54 | 18.40 | ||
Nomura Global Equity Fund TWD | 3.89B | 13.94 | 6.48 | 10.31 | ||
Nomura Taiwan Small Cap Fund | 8.27B | 12.10 | 17.63 | 18.66 | ||
Nomura Taiwan Growth Fund | 2.79B | 11.01 | 15.96 | 17.70 | ||
Nomura Taiwan Growth Selection Fund | 2.15B | 11.89 | 19.70 | 16.77 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review